Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Aqua Metals | AQMS | Nov 27, 2024 | 2.30 | +1.77 |
AquaBounty Technologies | AQB | Nov 27, 2024 | 0.96 | -2.53 |
Aquaron Acquisition | AQU | Nov 27, 2024 | 11.10 | 0.00 |
Aquaron Acquisition Units | AQUNU | Nov 27, 2024 | 11.15 | 0.00 |
Aquestive Therapeutics | AQST | Nov 27, 2024 | 5.16 | +5.74 |
Aramark | ARMK | Nov 27, 2024 | 40.77 | -3.43 |
ARB IOT Group | ARBB | Nov 27, 2024 | 0.51 | +10.82 |
Arbe Robotics | ARBE | Nov 27, 2024 | 1.78 | -6.81 |
Arbor Realty Trust | ABR | Nov 27, 2024 | 14.80 | -0.27 |
Arbor Realty Trust D Pref | ABR-D | Nov 27, 2024 | 19.22 | -0.05 |
Arbor Realty Trust E Pref | ABR-E | Nov 27, 2024 | 18.79 | -2.29 |
Arbor Realty Trust F Pref | ABR-F | Nov 27, 2024 | 21.25 | +0.24 |
Arbutus Biopharma | ABUS | Nov 27, 2024 | 3.47 | +1.76 |
ARC Document Solutions | ARC | Nov 27, 2024 | 3.39 | 0.00 |
Arcadia Biosciences | RKDA | Nov 27, 2024 | 2.76 | 0.00 |
Arcadium Lithium | ALTM | Nov 27, 2024 | 5.23 | 0.00 |
ArcBest | ARCB | Nov 27, 2024 | 113.50 | +0.40 |
Arcellx | ACLX | Nov 27, 2024 | 89.07 | -2.08 |
Arcelor Mittal ADR | MT | Nov 27, 2024 | 24.56 | +2.59 |
Arch Capital F Pref | ACGLO | Nov 27, 2024 | 22.65 | 0.00 |
Arch Capital G | ACGLN | Nov 27, 2024 | 19.63 | -0.41 |
Arch Capital Group | ACGL | Nov 27, 2024 | 100.74 | +0.33 |
Arch Resources A | ARCH | Nov 27, 2024 | 173.36 | -0.58 |
Archer Aviation A | ACHR | Nov 27, 2024 | 8.08 | +11.91 |
Archer Daniels Midland | ADM | Nov 27, 2024 | 54.37 | +1.21 |
Archrock | AROC | Nov 27, 2024 | 24.92 | -1.27 |
Arcos Dorados | ARCO | Nov 27, 2024 | 8.20 | -0.36 |
Arcosa | ACA | Nov 27, 2024 | 107.37 | -1.34 |
Arcturus Therapeutics | ARCT | Nov 27, 2024 | 17.51 | +3.43 |
Arcus Biosciences | RCUS | Nov 27, 2024 | 15.80 | +0.06 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.